The simultaneous advances in biotechnology, material sciences, synthetic chemistry, and information technology are integrating to provide novel approaches to insulin-dependent diabetes that were impossible as recent as a decade ago. With more than half a billion people affected globally by diabetes there is an abundance of ongoing research — therapeutically and technology-wise — to address the escalating threat to personal health and national economies.